Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 5,569-5,580 of 5,650
Drug study icon
RecruitingNCT06445933

Vitamin B6 and Depression in Pregnant and Peri-partum Women

This study is comparing Vitamin B6 with placebo for people with Postpartum Depression or Heart Rate Variability. Participants receive Vitamin B6 or placebo and complete study visits and assessments.

In Taipei
DepressionDrugA study involving a medication or substance.From 20 Years to 50 Years
Countries
Taiwan
Sponsor
National Taiwan University Hospital
Condition
Depression
Other study type icon
RecruitingISRCTN70909899

Vitamin D and non-specific musculoskeletal complaints in non-Western immigrants

This study is looking at whether questionnaires and follow-up can help people with Locomotor, Depression/bad mood, general practice, Musculoskeletal Diseases, or Vitamin D deficiency, unspecified. Participants take part in the program and complete follow-up questionnaires or assessments.

In Netherlands
DepressionOtherFrom 18 Years to 60 Years
Countries
Netherlands
Sponsor
Individual sponsor (Netherlands)
Condition
Depression
Other study type icon
RecruitingISRCTN12424842

Vitamin D supplementation compared to placebo in people presenting with their first episode of psychosis neuroprotection design

This study is looking at care and outcomes for people with Psychosis or Mental and Behavioural Disorders. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

In United Kingdom
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
Other study type icon
RecruitingISRCTN18801971

VIVALDI Praxis: Valdoxan improves depressive symptoms and normalizes circadian rhythms

This observational study is following people with Episodes of major depression, Mental and Behavioural Disorders, or Recurrent depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Germany
DepressionOther
Countries
Germany
Sponsor
Servier Deutschland GmbH (Germany)
Condition
Depression
Other study type icon
RecruitingISRCTN49411996

VIVALDI: Valdoxan® improves depressive symptoms and normalises circadian rhythms

This observational study is following people with Episodes of major depression, Mental and Behavioural Disorders, or Depressive episode to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Germany
DepressionOtherOver 18 Years
Countries
Germany
Sponsor
Servier Deutschland GmbH (Germany)
Condition
Depression
Biological study icon
RecruitingNCT06613334

Voice-Based Biomarkers: a Novel Approach to Monitoring and Predicting Schizophrenia Relapses

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Paris
SchizophreniaBiologicalFrom 18 Years to 60 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT06835556

Volatility in Paranoia (VIP) study: An RCT of Changes in Volatility With Psychotherapy

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can make care clearer and more responsive. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can give earlier or clearer feedback during care.

In Nashville
SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
Other study type icon
RecruitingNCT07579481

Vortioxetine in Depression and Concomitant Migraine

This summary needs review. Please check the official study record and contact the research team for details.

In Rome
DepressionOtherOver 18 Years
Countries
Italy
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Condition
Depression
Behavioral study icon
RecruitingISRCTN72046738

VP3: Vancouver primary prevention project (anxiety disorders prevention in school children)

This study is looking at whether Cognitive behavior therapy (CBT) or an attention control procedure (storytelling) Trial details received: 12 Sept 2005 can help people with anxiety or Mental and Behavioural Disorders. Participants take part in Cognitive behavior therapy (CBT) or an attention control procedure (storytelling) Trial details received: 12 Sept 2005 and complete follow-up assessments.

In Canada
AnxietyOtherFrom 5 Years to 11 Years
Countries
Canada
Sponsor
University of British Columbia (Canada)
Condition
Anxiety
Behavioral study icon
RecruitingNCT07122843

VR AI Meditation for Pain

This summary needs review. Please check the official study record and contact the research team for details.

In Los Angeles
AnxietyBehavioralOver 18 Years
Countries
United States
Sponsor
Christopher Almario
Condition
Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.